Table 1. Baseline characteristics of subjects.
| 30-mL/12h (n = 121) | 30-mL/24h (n = 124) | 80-mL/12h (n = 125) | 80-mL/24h (n = 125) | p | |
|---|---|---|---|---|---|
| Maternal age (years; mean ± SD) | 28.0 ± 3.4 | 28.4 ± 3.5 | 28.4 ± 3.4 | 28.4 ± 3.7 | 0.829 |
| Parity n (%) | 0.684 | ||||
| 0 | 114 (94.2) | 117 (94.4) | 113 (90.4) | 118 (94.4) | |
| 1 | 7 (5.8) | 6 (4.8) | 11 (8.8) | 7 (5.6) | |
| 2 | 0 (0.0) | 1 (0.8) | 1 (0.8) | 0 (0.0) | |
| Bishop score (median [IQR]) | 4 (4–5) | 4 (4–5) | 4 (4–5) | 4(4–5) | 0.265 |
| GA (weeks; median [IQR]) | 40.1 (39.3–41.0) | 41.0 (39.4–41.0) | 40.0 (39.1–41.0) | 40.4 (39.6–41.0) | 0.360 |
| Indications for induction n (%) | |||||
| GA ≥ 41 weeks | 59 (48.8) | 73 (58.9) | 55 (43.7) | 56 (44.8) | |
| GDM/Diabetes | 42 (34.7%) | 31 (25.0%) | 31 (24.8%) | 43 (34.4%) | |
| HDP | 8 (6.6%) | 7 (5.6%) | 19 (15.2%) | 13 (10.4%) | |
| FGR | 1 (0.8%) | 2 (1.6%) | 8 (6.4%) | 3 (2.4%) | |
| Oligohydramnion | 9 (7.4%) | 7 (5.6%) | 9 (7.2%) | 9 (7.2%) | |
| Other | 2 (1.7%) | 4 (3.2%) | 3 (2.4%) | 1 (0.8%) | |
GA, gestational age. GDM, gestational diabetes mellitus. HDP, hypertensive disorders in pregnancy. FGR, fetal growth restriction.